Skip to content

Healthy Aging Through Movement

The Potential of Exercise to Reduce Pain and Enhance Mobility in Mid-life Adults Undergoing Opioid Use Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05772884
Acronym
HELM
Enrollment
6
Registered
2023-03-16
Start date
2022-05-11
Completion date
2025-10-09
Last updated
2025-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Keywords

Pain, Exercise

Brief summary

This study aims to examine the effectiveness of a supervised aerobic exercise program for persons with Opioid Use Disorder (OUD). Participants will be enrolled in a 12-week supervised aerobic exercise intervention.

Detailed description

The overall project goals are to test the feasibility and acceptability of our aerobic exercise intervention with this population. Study participation will include a screening and enrollment phase, a baseline assessment, and a 12-week intervention. Participants will be recruited and consented by University of Florida (UF) study staff.

Interventions

OTHERSupervised Exercise Intervention

Exercise duration will be gradually increased as tolerated to 50 min/session, with intensity ramping up to 65-75% HRmax by week 3. On-site exercise sessions will occur along a pre-marked walking path, and a trained staff member will walk alongside the participant to monitor their heart rate. Speed will be manipulated to achieve desired intensity and to sustain heart rate in the target zone. Heart rate will be monitored and recorded via telemetry during the on-site exercise sessions. Step cadence (i.e., steps/minute) will also be monitored and recorded during the on-site sessions and discussed with participants as a way to understand and track their speed when completing off-site walking sessions on their own.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

All participants receive the same (single) intervention.

Eligibility

Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults must be aged 21-64 years old * Currently enrolled in OMT (opioid maintenance treatment) or present with at least mild opioid use disorder (endorses at least 2 DSM-V criteria for OUD within a 12-month period), * Insufficiently physically active (defined as exercising \< 20 minutes 3 times/week * Able to understand and speak English * Have a body mass index 18.5-40 kg/m\^2 * Willing and able to visit research center up to one time time/week for 12 weeks * Participants will undergo a supervised maximal exercise test and physical exam by medical supervisor to be cleared for participation.

Exclusion criteria

* Participants must not have heart disease, or had a stroke, uncontrolled diabetes, thyroid condition an eating disorder * An uncontrolled major psychiatric condition (e.g., schizophrenia; conditions that are well-controlled, however \[e.g., anxiety controlled through therapy\] will not be exclusionary), or other medical condition(s) that contraindicate exercise; and may not be participating in a structured exercise training or weight loss program. * Participants cannot be pregnant; pregnancy is exclusionary * One individual per household may enroll.

Design outcomes

Primary

MeasureTime frameDescription
Recruitment feasibilityBaseline up to 4 weeksNumber of participants screened and enrolled with reasons for ineligibility and non-participation recruitment rate (participants enrolled/month
Intervention adherenceUp to 13 weeksMeasured as percent study sessions completed on-time (+/- 1 hour of the scheduled session) and the proportion of participants who achieved \>75% adherence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026